OPTIFarm is the world’s only real-time, remote, 24/7 optimisation service for livestock farms. The company argues that current livestock production facilities lack a systematic way of monitoring production, animal welfare or staff training needs on a continuous basis. It stresses that its model combines the knowledge of trained experts with raw data gathered from livestock consisting of metrics like feed consumption, feed availability, water, temperature, humidity, and air pressure. The company combines the aforementioned data with advanced software and data analytics offering livestock businesses 24/7 monitoring providing full status reports every 90 minutes. OPTIFarm asserts that this enables farms to optimise feed, water and climate to provide the best conditions for their livestock. OPTIFarm’s service is currently generating c. £25,000 per month in recurring revenues from poultry clients in 14 countries across the globe. The company stated it will use the investment received to prepare the business for rapid scale-up growth over the next five years.
days to go:
Expired
investment:
Withheld
MiiCARE is a company that provides AI-based in-home companionship & health support for the elderly. miiCARE provides an 18-month product validation process with the NHS and the elderly. Its innovation miiCUBE is a cloud-based assistive technology solution that can detect an emergency and inform a designated responder. miiCARE already has 250 prospective clients who have already expressed interest to purchase the product. The company was accepted for the 'Microsoft for Startups' program in 2019 and Microsoft's 'AI for Good' acceleration cohort in 2020. The company will utilise the investments to create an emergency stock to support future orders, fulfill orders for clients, strengthen its team, and create a small inventory for orders.
days to go:
Expired
investment:
£354,632
Oyako is a distance-control application that aims to reduce the stresses and strains on children's eyes. The company asserts that an increase in mobile technology usage has led to an increase in myopia (nearsightedness) in children. It also leads to parents incurring a cost by way of purchasing spectacles along with a cost to the National Health Service (NHS) and medical insurance companies. By 2050, half of the global population will be short-sighted if current trends continue. Oyako aims to solve this issue through its application. Oyako's prototype app uses a simple traffic light design to signify safe or damaging scenarios, intelligently controls the phone camera without compromising battery usage, and is available on the App Store and Google Playstore. Oyako will use the investment to finalise its application and take it to market at £6.99 per download.
days to go:
Expired
investment:
£131,641
Vendoir aims to become the go-to app for instantly sourcing and booking event vendors on-demand with ease. It intends to operate as a marketplace model and earn revenue through commission on each transaction and via premium accounts. It asserts that it is part of the London & Partners Business Growth Programme Spring Cohort 2021. The company endeavours to disrupt the £43 billion UK events market post-Covid-19 with an on-demand app. It has a waitlist of more than 1300 interested clients and has featured in Forbes. The company will use the investment to accelerate its product launch.
days to go:
Expired
investment:
£172,457
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
A FCA-authorised and regulated digital credit card on smartphones, for those with modern and busy lifestyles. Jaja aims to offer a fair and transparent banking service that gives consumers greater confidence, control and freedom over their finances. The company has tested their app and card with Visa and has partnered with Asda to offer online credit instantly.
Jaja's business model allows revenue to be generated via interest payments from revolving lines of credit. Two products will be offered to consumers; the Jaja Credit Card and Jaja Pay. Both will be suitable for B2B and B2C operations.
Investments will be used to launch a beta round for 5,000 users to build a community before the products are publicly released. In addition, Jaja intends to expand its customer service team and produce marketing campaigns for their business.
days to go:
Expired
investment:
£4,957,534
Felcana is a patented Eco-system of connected devices: Helix, Home Hub, Micro-Location Beacons and the Felcana application which work together to monitor the pet's (cat or dogs) well-being. This Digital Pet Health Platform tracks pet's behaviour and provides the vet, rich data leading to faster diagnosis and faster treatment. Felcana has been developed by a world-class team of vets and engineers and, it has been designed and tested by using the latest materials, designs, and techniques. Felcana has won the Design Spark Award in 2017. It is making unique partnerships with leading pet industries and the UK's largest pet health plan provider, the world's top-ranked vet school and The Royal Veterinary College. The new investment will enable it to grow consumer reach and accelerate its sales.
days to go:
Expired
investment:
£343,926
Nikalyte is a specialist in nanoparticles research and development (R&D) as well as commercialisation in various application areas such as cell binding, cell separation, drug delivery, catalysis, nano-photonics, and electrochemistry. The company is developing a nanoparticle generator, which will enable researchers to produce nanoparticles of almost any metal or alloy on almost any substrate via a user-friendly interface. Nikalyte is offering free nanoparticle samples to researchers investigating antiviral materials, such as Copper and Silver, towards developing a vaccine for Covid-19. The company also offers a consultancy service that provides advice on nanoparticle applications and ultra-high vacuum systems. The company aims to use the investment to scale its business.
days to go:
Expired
investment:
Withheld
Iceni Labs is an innovative enterprise that develops and deploys cutting-edge technologies to build a safer and secure future. The company takes early-stage technology from the lab to the market by partnering with leading academics, researchers, and commercial experts. It has collaborated with the UK National Health Service’s (NHS) Royal Papworth Hospital to accelerate the development of a non-contact device, SafeScan, that monitors the breathing rate of an individual remotely. Iceni Labs also conducted a one-year clinical study of the device at Royal Papworth Hospital on a sample size of 400 patients. It has been awarded Innovate UK funding to build a prototype for monitoring care home residents. The company's goal is to become globally recognised as a catalyst for successful innovation.
days to go:
Expired
investment:
Withheld
GoCustomate has an aim to get rid of the pain points for the SME's when buying and selling by completely changing the way transactions occur. Till date, they have secured the licence to utilize third-party eMoney authorization from the Central Bank of Ireland, GoCustomate verifies its users, provides automated payment schedules and flexible escrow wallets. It also protects customers with their unique digital wallets. The company is fundraising to grow sales by focusing on SME customers with relevant pain points. With the proceeds, the company will expand across the EU and Australia.
days to go:
Expired
investment:
£156,300
